Article

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

2022-01-16

Abstract excerpt

<h4>Background</h4> <h4>Background: </h4> incidence rates are critical in pharmacovigilance to facilitate identification of vaccine safety signals. We estimated background incidence rates of nine adverse events of special interest related to COVID-19 vaccines in Ontario, Canada. <h4>Methods</h4> We conducted a population-based retrospective observational study using linked health administrative databases for hospi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 837b565e-d1d8-53d6-b44b-62a72296cf0f
DOI: 10.1101/2022.01.12.22269169

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceDOI 10.1101/2022.01.12.22269169Read

“Association between COVID-19 vaccination, infection, and risk of Guillain-Barre syndrome, Bell’s palsy, encephalomyelitis and transverse myelitis: a population-based cohort and self-controlled case series analysis”Semantic proximity Read

Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United StatesSemantic proximity Read

Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemicSemantic proximity Read

Cohort monitoring of 29 Adverse Events of Special Interest prior to and after COVID-19 vaccination in four large European electronic healthcare data sourcesSemantic proximity Read

Incidence and management of the main adverse effects reported after COVID-19 vaccinationSemantic proximity Read

Association between COVID-19 Vaccination and Neuropsychiatric ConditionsSemantic proximity Read

Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19Semantic proximity Read

Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19Semantic proximity Read

Factors associated with neurological manifestations in patients hospitalized with COVID-19 in a military hospitalSemantic proximity Read

Impact of the COVID-19 pandemic and vaccination on global, regional, and national burden of Guillain-Barré syndrome: observational studySemantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

Guillain-Barr é syndrome in COVID-19: A scoping reviewSemantic proximity Read